Medpace Holdings, Inc.
MX ˙ BMV ˙ US58506Q1094
SecurityMX:MEDP / Medpace Holdings, Inc.
InstitutionLindenwold Advisors
Latest Disclosed Ownership1,491 shares
Latest Disclosed Value $ 766,613
Lindenwold Advisors reports 21.73% decrease in ownership of MEDP / Medpace Holdings, Inc.

On December 16, 2025 - Lindenwold Advisors filed a 13F-HR form disclosing ownership of 1,491 shares of Medpace Holdings, Inc. (MX:MEDP) valued at $766,613 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 24, 2025 disclosing 1,905 shares of Medpace Holdings, Inc.. This represents a change in shares of -21.73% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-12-16 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 1,491 -414 -21.73 767 28.31 0.3622
2025-07-24 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 1,905 -2 -0.10 598 2.75 0.3106
2025-05-08 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 1,907 -47 -2.41 581 -10.48 0.3235
2025-02-11 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 1,954 -72 -3.55 649 -3.99 0.3466
2024-11-07 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 2,026 32 1.60 676 -17.66 0.3406
2024-08-13 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 1,994 -52 -2.54 821 -0.61 0.4383
2024-05-09 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 2,046 -7 -0.34 827 31.32 0.4422
2024-02-08 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 2,053 -17 -0.82 629 25.55 0.3575
2023-10-19 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 2,070 12 0.58 501 1.42 0.3121
2023-08-08 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 2,058 -484 -19.04 494 3.35 0.3030
2023-05-08 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 2,542 14 0.55 478 -10.82 0.2963
2023-02-13 2022-12-31 13F MEDPACE HLDGS COM 58506Q109 2,528 -279 -9.94 537 21.54 0.3598
2022-10-31 2022-09-30 13F MEDPACE HLDGS COM 58506Q109 2,807 32 1.15 441 6.27 0.3265
2022-08-05 2022-06-30 13F MEDPACE HLDGS COM 58506Q109 2,775 63 2.32 415 -6.53 0.2952
2022-05-09 2022-03-31 13F MEDPACE HLDGS COM 58506Q109 2,712 148 5.77 444 -20.43 0.2726
2022-02-14 2021-12-31 13F MEDPACE HLDGS COM 58506Q109 2,564 2,564 558 0.3256
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.